Cystic Fibrosis
📧 Sign up to get email alerts when something new happens for Cystic Fibrosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-08-29Clinical Trial Update: Cystic Fibrosis and Totally Implantable Vascular Access Devices [Phase 4]
Phase 4 clinical trial evaluating totally implantable vascular access devices in patients with cystic fibrosis and venous thrombosis; study …
-
CLINICAL_TRIALS trial_result · 2011-08-24Clinical Trial Update: Tolerability of Inhaled Hypertonic Saline in Infants With Cystic Fibrosis [NA]
This clinical trial evaluated the tolerability of inhaled hypertonic saline in infants with cystic fibrosis. The study is completed.
-
CLINICAL_TRIALS trial_result · 2011-08-23Clinical Trial Update: Study About Complications of Totally Implanted Venous Access Devices (TIVADs) in People With Cystic Fibrosis (CF)
A completed clinical trial evaluated complications associated with totally implanted venous access devices (TIVADs) in people with cystic fi…
-
CLINICAL_TRIALS trial_result · 2011-08-23Clinical Trial Update: Evaluation of the Emission Distance of P. Aeruginosa From the Respiratory Tract of People With Cystic Fibrosis
A completed clinical trial from the University of Florence evaluated the distance that Pseudomonas aeruginosa can be emitted from the respir…
-
CLINICAL_TRIALS trial_result · 2011-08-15Clinical Trial Update: The Effect of Inhaled N-Acetylcysteine Compared to Normal Saline on Sputum Rheology and Lung Function [Phase 4]
A Phase 4 trial comparing inhaled N-acetylcysteine to normal saline in cystic fibrosis was terminated; the study aimed to assess sputum rheo…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-08-10Clinical Trial Update: Does a Nasal Instillation of Miglustat Normalize the Nasal Potential Difference in Cystic Fibrosis Patients ? [Phase 2]
A Phase 2 trial evaluating nasal instillation of miglustat to normalize nasal potential difference in cystic fibrosis patients has completed…
-
CLINICAL_TRIALS trial_result · 2011-08-08Clinical Trial Update: Dose Escalation Study of KB001 in Cystic Fibrosis Patients Infected With Pseudomonas Aeruginosa [Phase 1, Phase 2]
A dose-escalation Phase 1/2 trial of KB001 in cystic fibrosis patients infected with Pseudomonas aeruginosa has completed, and results were …
-
CLINICAL_TRIALS trial_result · 2011-08-04Clinical Trial Update: An Exploratory Study to Assess Multiple Doses of Omalizumab in Patients With Cystic Fibrosis Complicated by Acute Bronchopulmonary Aspergillosis (ABPA) [Phase 4]
Phase 4 exploratory study evaluating multiple doses of omalizumab in cystic fibrosis patients with allergic bronchopulmonary aspergillosis; …
-
CLINICAL_TRIALS trial_result · 2011-08-04Clinical Trial Update: Comparison of 2 Treatment Regimens for Eradication of P Aeruginosa Infection in Children With Cystic Fibrosis [Phase 4]
This Phase 4 trial compares two regimens for eradicating Pseudomonas aeruginosa infection in children with cystic fibrosis and reports updat…
-
CLINICAL_TRIALS trial_result · 2011-07-19Clinical Trial Update: Inhaled Sodium Pyruvate for the Treatment of Cystic Fibrosis. [Phase 1]
A Phase 1 trial evaluating inhaled sodium pyruvate for cystic fibrosis has completed.
-
CLINICAL_TRIALS trial_result · 2011-07-04Clinical Trial Update: Aztreonam for Inhalation Solution vs Tobramycin Inhalation Solution in Patients With Cystic Fibrosis & Pseudomonas Aeruginosa [Phase 3]
Phase 3 trial comparing aztreonam for inhalation solution with tobramycin inhalation solution in cystic fibrosis patients with Pseudomonas a…
-
CLINICAL_TRIALS trial_result · 2011-06-30Clinical Trial Update: Phenylbutyrate/Genistein Duotherapy in Delta F508-Heterozygotes (for Cystic Fibrosis) [Phase 1, Phase 2]
A phase 1/2 trial of phenylbutyrate and genistein duotherapy in Delta F508-heterozygous cystic fibrosis patients was terminated, with result…
-
CLINICAL_TRIALS trial_result · 2011-06-17Clinical Trial Update: A Study of Pulmozyme® (Dornase Alpha) in 3- to 5-Year-Old Patients With Cystic Fibrosis [Phase 4]
Phase 4 clinical trial of Pulmozyme (dornase alfa) in 3- to 5-year-old children with cystic fibrosis was terminated; results were posted in …
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: Choline Nutrition in Children With Cystic Fibrosis (CF) [NA]
A clinical trial evaluating choline nutrition in children with cystic fibrosis has completed.
-
CLINICAL_TRIALS trial_result · 2011-05-19Clinical Trial Update: An Effectiveness, Safety, and Palatability Study of Pancrelipase Microtablets in Infants and Toddlers With Cystic Fibrosis and Fat Malabsorption [Phase 2]
Phase 2 trial assessing effectiveness, safety, and palatability of pancrelipase microtablets in infants and toddlers with cystic fibrosis an…
-
CLINICAL_TRIALS trial_result · 2011-04-21Clinical Trial Update: International Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis Patients With P. Aeruginosa [Phase 3]
Phase 3 trial update for aztreonam for inhalation solution (Cayston) evaluating safety and efficacy in cystic fibrosis patients with Pseudom…
-
CLINICAL_TRIALS trial_result · 2011-04-18Clinical Trial Update: Short Term Safety and Efficacy of Lubiprostone in Adults With Cystic Fibrosis [NA]
Clinical trial update reporting short-term safety and efficacy results of lubiprostone in adults with cystic fibrosis, with constipation lis…
-
CLINICAL_TRIALS trial_result · 2011-04-18Clinical Trial Update: Comparison of Antibiotics for Pseudomonas in Early CF [Phase 1]
Phase 1 trial comparing antibiotics for Pseudomonas infection in early cystic fibrosis has completed.
-
CLINICAL_TRIALS trial_result · 2011-04-13Clinical Trial Update: Safety and Efficacy of 12-wk Treatment With Two Doses of Tiotropium Respimat in Cystic Fibrosis [Phase 2]
Phase 2 trial evaluating the safety and efficacy of a 12-week two-dose tiotropium Respimat regimen in cystic fibrosis.
-
CLINICAL_TRIALS trial_result · 2011-03-30Clinical Trial Update: Phase I Study of Liposome-Mediated Gene Transfer in Patients With Cystic Fibrosis [Phase 1]
This is a completed Phase I clinical trial evaluating liposome-mediated gene transfer in patients with cystic fibrosis.
-
CLINICAL_TRIALS trial_result · 2011-03-29Clinical Trial Update: Phase I Pilot Study of Gene Therapy for Cystic Fibrosis Using Cationic Liposome Mediated Gene Transfer [Phase 1]
Phase I pilot study evaluating cationic liposome–mediated gene transfer for cystic fibrosis; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2011-03-11Clinical Trial Update: Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis (CF) Patients With Pseudomonas Aeruginosa (PA) [Phase 3]
Phase 3 clinical trial evaluating aztreonam for inhalation solution (AZLI) in cystic fibrosis patients with Pseudomonas aeruginosa completed…
-
CLINICAL_TRIALS trial_result · 2011-03-11Clinical Trial Update: Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis Patients With P. Aeruginosa [Phase 3]
Phase 3 study evaluating aztreonam for inhalation solution (AZLI) in cystic fibrosis patients with Pseudomonas aeruginosa has completed and …
-
CLINICAL_TRIALS trial_result · 2011-02-16Clinical Trial Update: Evaluation of Bronchial Inflammation in Allergic Bronchopulmonary Aspergillosis (ABPA)
A completed clinical trial evaluating bronchial inflammation in Allergic bronchopulmonary aspergillosis (ABPA) in patients with cystic fibro…
-
CLINICAL_TRIALS trial_result · 2011-01-12Clinical Trial Update: Study of VX-770 in Subjects With Moderate Hepatic Impairment and in Matched Healthy Subjects [Phase 1]
Phase 1 pharmacokinetic and safety study of VX-770 (ivacaftor) in subjects with moderate hepatic impairment and matched healthy controls has…